Latest Breaking News On - Ustekinumab induction - Page 1 : comparemela.com

/PRNewswire/ The Janssen Pharmaceutical Companies of Johnson & Johnson today announced final pooled long-term safety results for STELARA® (ustekinumab).

Spring houseBritish columbiaUnited statesWaqqas afifJan wehkampColitis organizationDivision of experimental medicineCrohn colitis foundationJanssen research developmentJanssen pharmaceutical companiesJanssen pharmaceutical companies of johnsonDepartment of medicineUniversity health centreNone of the janssen pharmaceutical companiesDivision of gastroenterologyNational institutes of health